Ab&B Bio-Tech CO., LTD. JS (HKG:2627)
Hong Kong · Delayed Price · Currency is HKD
48.70
-1.10 (-2.21%)
Sep 5, 2025, 10:44 AM HKT
HKG:2627 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
TTM | FY 2024 | FY 2023 |
---|
Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
---|
| 114.56 | 132.19 | 45.32 |
| - | - | 22.24 |
| - | - | 10.02 |
Cash & Short-Term Investments | 114.56 | 132.19 | 77.57 |
| - | 70.41% | - |
| 221.28 | 284.91 | 73.6 |
| 20.93 | 20.49 | 14.77 |
| 242.21 | 305.4 | 88.37 |
| 87.37 | 57.81 | 41.82 |
| 0.14 | 0.14 | 5.49 |
| 444.28 | 495.54 | 213.25 |
Property, Plant & Equipment | 1,028 | 1,031 | 835.26 |
| 7.18 | 7.66 | 8.84 |
Long-Term Deferred Charges | 18 | 18 | 18 |
| 63.45 | 60.86 | 44.4 |
|
| 420.16 | 441.62 | 89.36 |
| - | - | 58.63 |
| 12.59 | 27.67 | - |
Current Portion of Long-Term Debt | 392.71 | 347.52 | 217.89 |
Current Portion of Leases | 8.03 | 7.15 | 6.47 |
Other Current Liabilities | 81.06 | 84.72 | 156.82 |
Total Current Liabilities | 914.54 | 908.68 | 529.16 |
| 490.41 | 462.01 | 148.26 |
| 40.39 | 42.13 | 48.81 |
Long-Term Unearned Revenue | 36.81 | 37.02 | 30.24 |
Other Long-Term Liabilities | 16.42 | 16.42 | - |
|
| 360 | 360 | 360 |
Additional Paid-In Capital | 691.37 | 691.37 | 614.93 |
| -1,056 | -969.08 | -710.36 |
Comprehensive Income & Other | 67.2 | 64.3 | 98.7 |
|
Total Liabilities & Equity | 1,561 | 1,613 | 1,120 |
| 944.13 | 886.48 | 421.42 |
| -829.57 | -754.29 | -343.85 |
| -2.30 | -2.10 | -0.96 |
Filing Date Shares Outstanding | 360 | 360 | 360 |
Total Common Shares Outstanding | 360 | 360 | 360 |
| -470.26 | -413.14 | -315.92 |
| 0.17 | 0.41 | 1.01 |
| 54.99 | 138.93 | 354.43 |
Tangible Book Value Per Share | 0.15 | 0.39 | 0.98 |
| 137.39 | 137.39 | 107 |
| 12.83 | 12.82 | 12.61 |
| 423.74 | 411.97 | 351.99 |
| 16.74 | 16.74 | 16.44 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.